These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 187015)

  • 1. [Formation of Escherichia coli resistance to amidine penicillin].
    Zapasnik M; Morris-Rostkowska W; Chojnowski W
    Acta Pol Pharm; 1976; 33(5):663-4. PubMed ID: 187015
    [No Abstract]   [Full Text] [Related]  

  • 2. The two sites of penicillin action in Escherichia coli.
    Greenwood D; O'Grady F
    J Infect Dis; 1973 Dec; 128(6):791-4. PubMed ID: 4358124
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined effect of 6/N,N-1',6'-hexyleneformamidine-penicillanic acid (preparation HX) and selected beta-lactam antibiotics on E. coli and Salmonella. I. Studies in vitro].
    Zaremba M; Zukowska-Nytko K; Borowski J
    Med Dosw Mikrobiol; 1982; 34(1-2):27-36. PubMed ID: 6292594
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sensitivity of Enterobacteriaceae isolated from humans to 6-N,N-1',6'-hexyleneformamidine-penicillanic acid (preparation HX)].
    Zaremba M; Zukowska-Nytko K; Grala-Kałuzna A; Kacprzak-Wiatr A; Piotrowski J; Kulikowska A; borowski J
    Med Dosw Mikrobiol; 1982; 34(1-2):17-26. PubMed ID: 6292593
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on beta-lactam antibiotics. V. Synthesis of 6-[D(-)-alpha-(acylamino)-4-hydroxyphenylacetamido]penicillanic acids and antibacterial activity (author's transl)].
    Tobiki H; Yamada H; Tanno N; Shimago K; Eda Y; Noguchi H; Komatsu T; Nakagome T
    Yakugaku Zasshi; 1980 Feb; 100(2):133-9. PubMed ID: 6245204
    [No Abstract]   [Full Text] [Related]  

  • 6. FL 1060: a new beta-lactam antibiotic with novel properties.
    Greenwood D; O'Grady F
    J Clin Pathol; 1973 Jan; 26(1):1-6. PubMed ID: 4348402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light and electron microscopy of the early response of Escherichia coli to a 6beta-amidinopenicillanic acid (FL 1060).
    Melchior NH; Blom J; Tybring L; Birch-Andersen A
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Aug; 81(4):393-407. PubMed ID: 4358286
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of penicillin amidase activity in Escherichia coli.
    Wojskowicz J
    Acta Microbiol Pol; 1981; 30(1):13-23. PubMed ID: 6167144
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hetacillin: microbiological activity in vitro].
    Ravagnan L; Dominici A; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Sep; 7(3):187-98. PubMed ID: 4337877
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood levels and antibacterial activity of sera in patients treated with cyclacillin.
    Yourassowsky E; Schoutens E; Vanderlinden MP; Butzler JP; Sternon J
    Int J Clin Pharmacol; 1974 Mar; 9(2):120-4. PubMed ID: 4151243
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bacteremia by Escherichia coli resistant to amoxycillin/clavulanic acid, ampicillin/sulbactam and piperacillin/tazobactam].
    Alós JI; Gómez-Garcés JL; Mateos MV
    Med Clin (Barc); 1994 Feb; 102(5):197-8. PubMed ID: 8127173
    [No Abstract]   [Full Text] [Related]  

  • 12. Irreproducible piperacillin/tazobactam minimum inhibitory concentrations in microdilution tests with Escherichia coli strains.
    Thomson KS; Black J; Moland ES; Reuben J; Wiles T; Brasso W
    Int J Antimicrob Agents; 2008 Jan; 31(1):83-5. PubMed ID: 17996426
    [No Abstract]   [Full Text] [Related]  

  • 13. Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital.
    Petrikkos G; Markogiannakis A; Papaparaskevas J; Daikos GL; Stefanakos G; Zissis NP; Avlamis A
    Int J Antimicrob Agents; 2007 Jan; 29(1):34-8. PubMed ID: 17189092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Semisynthetic penicillins. 13. Comparative studies of antibacterial action in vitro of 6-(N,N-1',6'-hexylenformamidino)-penicillanic acid and(D- (D-(minus) alpha-aminobenzyl)-penicillanic acid against clinical pathogenic gram negative strains].
    Jastalska D; Dzierzyńska I; Buśko-Oszczapowicz I; Cieślak J
    Acta Pol Pharm; 1974; 31(3):393-400. PubMed ID: 4368251
    [No Abstract]   [Full Text] [Related]  

  • 15. [Semi-synthetic penicillins. XI. Antimicrobial in vitro action of 6-formamidinopenicillanic acids, derivatives of some secondary cyclic amines].
    Chojnowski W; Kaluza A; Buśko-Oszczapowicz I; Cieślak J
    Acta Pol Pharm; 1973; 30(4):437-42. PubMed ID: 4357641
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum beta-lactamase.
    Shahid M; Singhai M; Malik A; Shukla I; Khan HM; Shujatullah F; Tahira F
    J Antimicrob Chemother; 2007 Jul; 60(1):187-8. PubMed ID: 17491002
    [No Abstract]   [Full Text] [Related]  

  • 17. Temperature-sensitive 6-aminopenicillanic acid-resistant mutants of Escherichia coli.
    Ishiguro EE; Iwaya M; Turley W
    Antimicrob Agents Chemother; 1979 Dec; 16(6):849-54. PubMed ID: 231413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
    Pitout JD; Le P; Church DL; Gregson DB; Laupland KB
    Int J Antimicrob Agents; 2008 Oct; 32(4):333-8. PubMed ID: 18701262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of tazobactam pharmacokinetics on the antimicrobial effect of piperacillin-tazobactam combinations.
    Liu Q; Rand K; Derendorf H
    Int J Antimicrob Agents; 2004 May; 23(5):494-7. PubMed ID: 15120729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Bishara J; Livne G; Ashkenazi S; Levy I; Pitlik S; Ofir O; Lev B; Samra Z
    Isr Med Assoc J; 2005 May; 7(5):298-301. PubMed ID: 15909461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.